Acuity Inc (DE
9 nominees · 3 ballot items.
Election of nine directors; ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal 2026; and advisory vote to approve named executive officer compensation.
Follow how the vote landed and what changed on Acuity Inc (DE’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of nine directors
ManagementBoard: FORElection of nine director nominees to serve one-year terms expiring at the next annual meeting or until a successor is elected or qualified.
- 2
Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm
ManagementBoard: FORRatification of EY as our independent registered public accounting firm for fiscal 2026.
- 3
Advisory vote to approve named executive officer compensation
ManagementBoard: FORAdvisory vote to approve the compensation of our named executive officers (Say on Pay) for fiscal 2025 as disclosed in this Proxy Statement.
Nominees on the ballot9
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Curated Wealth Partners LLC | 0.1% | 26,036 | $112K |
| 2 | REINHART PARTNERS, LLC. | 0.1% | 19,674 | $7M |
| 3 | QRG CAPITAL MANAGEMENT, INC. | 0.1% | 15,260 | $6M |
| 4 | Assenagon Asset Management S.A. | 0.1% | 15,109 | $6M |
| 5 | Guardian Wealth Management, Inc. | 0.0% | 11,316 | $4M |
| 6 | Gradient Investments LLC | 0.0% | 7,308 | $3M |
| 7 | SALEM INVESTMENT COUNSELORS INC | 0.0% | 3,222 | $1M |
| 8 | PRIVATE CLIENT SERVICES, LLC | 0.0% | 3,205 | $1M |
| 9 | Ferguson Shapiro LLC | 0.0% | 2,901 | $1M |
| 10 | Legacy Wealth Asset Management, LLC | 0.0% | 1,883 | $709K |
Other Industrials sector meetings6
Upcoming shareholder meetings at Acuity Inc (DE’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Acuity Inc (DE 2026 annual meeting?
- Acuity Inc (DE (AYI) holds its 2026 annual shareholder meeting on Wednesday, January 21, 2026.
- What is the record date for the Acuity Inc (DE 2026 meeting?
- The record date for the Acuity Inc (DE 2026 meeting is Monday, November 24, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Acuity Inc (DE's 2026 meeting?
- The board is presenting 9 director nominees at the Acuity Inc (DE 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Acuity Inc (DE 2026 meeting?
- Shareholders will vote on 3 proposals at the Acuity Inc (DE 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.